These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 5577970)

  • 1. Pharmacokinetics of warfarin following intravenous administration to man.
    O'Reilly RA; Welling PG; Wagner JG
    Thromb Diath Haemorrh; 1971; 25(1):178-86. PubMed ID: 5577970
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of plasma levels of antipyrine, tolbutamide, and warfarin after oral and intravenous administration.
    Andreasen PB; Vesell ES
    Clin Pharmacol Ther; 1974 Dec; 16(6):1059-65. PubMed ID: 4611464
    [No Abstract]   [Full Text] [Related]  

  • 3. A model solution for intestinal absorption of warfarin. A drug with non-linear distribution pharmacokinetics in the rat.
    Julkunen RJ; Kekki M; Wahlström B
    Arzneimittelforschung; 1980; 30(2):264-7. PubMed ID: 7378103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Warfarin pharmacokinetics in the horse.
    Thijssen HH; van den Bogaard AE; Wetzel JM; Maes JH; Muller AP
    Am J Vet Res; 1983 Jul; 44(7):1192-6. PubMed ID: 6881659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of microdosing to predict pharmacokinetics at the therapeutic dose: experience with 5 drugs.
    Lappin G; Kuhnz W; Jochemsen R; Kneer J; Chaudhary A; Oosterhuis B; Drijfhout WJ; Rowland M; Garner RC
    Clin Pharmacol Ther; 2006 Sep; 80(3):203-15. PubMed ID: 16952487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rodenticidal activity of warfarin. 2. Kinetics].
    Niedner R; Kayser M; Meyer F
    Arzneimittelforschung; 1974 Jun; 24(6):522-4. PubMed ID: 4408102
    [No Abstract]   [Full Text] [Related]  

  • 7. Kinetics of warfarin absorption in man.
    Breckenridge A; Orme M
    Clin Pharmacol Ther; 1973; 14(6):955-61. PubMed ID: 4584153
    [No Abstract]   [Full Text] [Related]  

  • 8. [Acquired warfarin resistance in a patient with mechanical heart valve].
    Gøtze JP; Thorsen S; Haunsø S
    Ugeskr Laeger; 2001 Dec; 163(50):7075-6. PubMed ID: 11794043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple doses of sitagliptin, a selective DPP-4 inhibitor, do not meaningfully alter pharmacokinetics and pharmacodynamics of warfarin.
    Wright DH; Herman GA; Maes A; Liu Q; Johnson-Levonas AO; Wagner JA
    J Clin Pharmacol; 2009 Oct; 49(10):1157-67. PubMed ID: 19783710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting anticoagulant response [proceedings].
    Davies DM; Rawlins MD; Routledge PA
    Br J Clin Pharmacol; 1977 Oct; 4(5):636P. PubMed ID: 911621
    [No Abstract]   [Full Text] [Related]  

  • 11. Interaction of sodium warfarin and rifampin. Studies in man.
    O'Reilly RA
    Ann Intern Med; 1974 Sep; 81(3):337-40. PubMed ID: 4852505
    [No Abstract]   [Full Text] [Related]  

  • 12. Gender differences in pharmacokinetics of oral warfarin in rats.
    Zhu X; Shin WG
    Biopharm Drug Dispos; 2005 May; 26(4):147-50. PubMed ID: 15776499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of drug action in man.
    Levy G
    Acta Pharmacol Toxicol (Copenh); 1971; 29 Suppl 3():203-10. PubMed ID: 5316402
    [No Abstract]   [Full Text] [Related]  

  • 14. Stereoselective interaction of phenylbutazone with [12C/13C]warfarin pseudoracemates in man.
    O'Reilly RA; Trager WF; Motley CH; Howald W
    J Clin Invest; 1980 Mar; 65(3):746-53. PubMed ID: 7354137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The distribution of warfarin (Coumadin) in the rat.
    Anderson GF
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):754-8. PubMed ID: 5590254
    [No Abstract]   [Full Text] [Related]  

  • 16. Developmental changes in pharmacokinetics and pharmacodynamics of warfarin enantiomers in Japanese children.
    Takahashi H; Ishikawa S; Nomoto S; Nishigaki Y; Ando F; Kashima T; Kimura S; Kanamori M; Echizen H
    Clin Pharmacol Ther; 2000 Nov; 68(5):541-55. PubMed ID: 11103757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous warfarin as an alternative for anticoagulation.
    Gellatly RM
    Pharmacotherapy; 2007 Jun; 27(6):933-5. PubMed ID: 17542775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of oral corticosteroids on chronic warfarin therapy.
    Hazlewood KA; Fugate SE; Harrison DL
    Ann Pharmacother; 2006 Dec; 40(12):2101-6. PubMed ID: 17119104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetics study of furosemide in healthy man (author's transl)].
    Gonzalez G; Arancibia A; Marinovic G; Moya JC; Antezana C; Ruiz I
    Therapie; 1980; 35(4):525-32. PubMed ID: 7466733
    [No Abstract]   [Full Text] [Related]  

  • 20. The contribution of plasma (R)- & (S)-warfarin and vitamin K concentrations to intra-individual variability in anticoagulation.
    Kamali F; Edwards C; Butler TJ; Wynne HA
    Thromb Haemost; 2000 Feb; 83(2):349-50. PubMed ID: 10739399
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.